Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
The report details the trend, potential and market size of Pet Cancer Therapeutics market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.
The first part (Chapter1-7) mainly covers the qualitative analysis of Pet Cancer Therapeuticsmarket, defines the market attractiveness level of Pet Cancer Therapeutics market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.
The second part (Chapter8-12), based on the segmentation of Pet Cancer Therapeutics industry, describes the types of Pet Cancer Therapeutics market, the applications of major players and the market size, and deeply analyzes the current situation of the global Pet Cancer Therapeutics market and the development prospects and opportunities of Pet Cancer Therapeutics industry.
The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.
As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Pet Cancer Therapeutics market in Chapter 13.
By Player:
Morphogenesis, Inc
Karyopharm Therapeutics, Inc
Zoetis
AB Science
Aratana Therapeutics, Inc
Zenoaq
Rhizen Pharmaceutical SA
Boehringer Ingelheim International GmbH
Oasmia Pharmaceuticals AB
Regeneus Ltd
VetDC, Inc
By Type:
Chemotherapy
Targeted Therapy
Combination Therapy
Immunotherapy
By End-User:
Immunotherapy
Immunotherapy
Immunotherapy
Immunotherapy
Immunotherapy
Immunotherapy
Immunotherapy
By Geography:
-
United States
-
Europe
-
China
-
Japan
-
India
-
South Korea
TABLE OF CONTENT
1 Introduction
-
1.1 Market Definition
-
1.2 Market Segment Analysis
-
1.3 Market Size 2022
-
1.4 Pet Cancer Therapeutics Market Outlook: Forecast for 2022 - 2028
-
1.5 Pricing Analysis
2 Executive Summary
3 Pet Cancer Therapeutics Market Lineage Outlook
-
3.1 Parent Market Outlook
-
3.2 Related/Ancillary Market Outlook
-
3.3 Penetration & Growth Prospect Mapping, 2022
4 Market Analysis Tools: Porter's Five Forces
-
4.1 Supplier Power
-
4.2 Buyer Power
-
4.3 Substitution Threat
-
4.4 Threat of New Entrants
-
4.5 Competitive Rivalry
5 Pet Cancer Therapeutics Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)
-
5.1 Political/Legal Landscape
-
5.2 Economic Landscape
-
5.3 Social Landscape
-
5.4 Technology Landscape
6 Pet Cancer Therapeutics Market - Value Chain Analysis
-
6.1 Industry's Value Chain Analysis
-
6.2 Product Life Cycle
-
6.3 User Perspective Analysis
7 Region and Country-wise Pet Cancer Therapeutics Market Analysis and Outlook to 2022
-
7.1 Global Pet Cancer Therapeutics Consumption (2017-2022)
-
7.2 United States Pet Cancer Therapeutics Consumption (2017-2022)
-
7.3 Europe Pet Cancer Therapeutics Consumption (2017-2022)
-
7.4 China Pet Cancer Therapeutics Consumption (2017-2022)
-
7.5 Japan Pet Cancer Therapeutics Consumption (2017-2022)
-
7.6 India Pet Cancer Therapeutics Consumption (2017-2022)
-
7.7 South Korea Pet Cancer Therapeutics Consumption (2017-2022)
8 Region and Country-wise Pet Cancer Therapeutics Market Analysis and Outlook to 2028
-
8.1 Global Pet Cancer Therapeutics Consumption Forecast (2022-2028)
-
8.2 United States Pet Cancer Therapeutics Consumption Forecast (2022-2028)
-
8.3 Europe Pet Cancer Therapeutics Consumption Forecast (2022-2028)
-
8.4 China Pet Cancer Therapeutics Consumption Forecast (2022-2028)
-
8.5 Japan Pet Cancer Therapeutics Consumption Forecast (2022-2028)
-
8.6 India Pet Cancer Therapeutics Consumption Forecast (2022-2028)
-
8.7 South Korea Pet Cancer Therapeutics Consumption Forecast (2022-2028)
9 Global Pet Cancer Therapeutics Market Outlook by Types and Applications to 2022
-
9.1 Global Pet Cancer Therapeutics Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global Chemotherapy Consumption and Growth Rate (2017-2022)
-
9.1.2 Global Targeted Therapy Consumption and Growth Rate (2017-2022)
-
9.1.3 Global Combination Therapy Consumption and Growth Rate (2017-2022)
-
9.1.4 Global Immunotherapy Consumption and Growth Rate (2017-2022)
-
9.2 Global Pet Cancer Therapeutics Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Immunotherapy Consumption and Growth Rate (2017-2022)
-
9.2.2 Global Immunotherapy Consumption and Growth Rate (2017-2022)
-
9.2.3 Global Immunotherapy Consumption and Growth Rate (2017-2022)
-
9.2.4 Global Immunotherapy Consumption and Growth Rate (2017-2022)
-
9.2.5 Global Immunotherapy Consumption and Growth Rate (2017-2022)
-
9.2.6 Global Immunotherapy Consumption and Growth Rate (2017-2022)
-
9.2.7 Global Immunotherapy Consumption and Growth Rate (2017-2022)
10 Global Pet Cancer Therapeutics Market Outlook by Types and Applications to 2028
-
10.1 Global Pet Cancer Therapeutics Consumption Forecast and Growth Rate by Type (2022-2028)
-
10.1.1 Global Chemotherapy Consumption Forecast and Growth Rate (2022-2028)
-
10.1.2 Global Targeted Therapy Consumption Forecast and Growth Rate (2022-2028)
-
10.1.3 Global Combination Therapy Consumption Forecast and Growth Rate (2022-2028)
-
10.1.4 Global Immunotherapy Consumption Forecast and Growth Rate (2022-2028)
-
10.2 Global Pet Cancer Therapeutics Consumption Forecast and Growth Rate by Application (2022-2028)
-
10.2.1 Global Immunotherapy Consumption Forecast and Growth Rate (2022-2028)
-
10.2.2 Global Immunotherapy Consumption Forecast and Growth Rate (2022-2028)
-
10.2.3 Global Immunotherapy Consumption Forecast and Growth Rate (2022-2028)
-
10.2.4 Global Immunotherapy Consumption Forecast and Growth Rate (2022-2028)
-
10.2.5 Global Immunotherapy Consumption Forecast and Growth Rate (2022-2028)
-
10.2.6 Global Immunotherapy Consumption Forecast and Growth Rate (2022-2028)
-
10.2.7 Global Immunotherapy Consumption Forecast and Growth Rate (2022-2028)
11 Global Pet Cancer Therapeutics Import and Export Analysis (Top 5 Countries)
-
11.1 Global Pet Cancer Therapeutics Import by Region (Top 5 Countries) (2017-2028)
-
11.2 Global Pet Cancer Therapeutics Export by Region (Top 5 Countries) (2017-2028)
12 Coronavirus Disease (COVID-19) Impact
-
12.1 Industry Impact Analysis
-
12.2 Pet Cancer Therapeutics Market Outlook to 2028 - COVID-19 Affected Forecasts
13 Competition Matrix
-
13.1 Target Markets
-
13.2 Comprehensive Analysis of Products in Competitive Markets
14 Global Pet Cancer Therapeutics Market Competitive Analysis
-
14.1 Morphogenesis, Inc
-
14.1.1 Morphogenesis, Inc Company Details
-
14.1.2 Morphogenesis, Inc Pet Cancer Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
14.1.3 Morphogenesis, Inc Pet Cancer Therapeutics Product and Service
-
14.2 Karyopharm Therapeutics, Inc
-
14.2.1 Karyopharm Therapeutics, Inc Company Details
-
14.2.2 Karyopharm Therapeutics, Inc Pet Cancer Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
14.2.3 Karyopharm Therapeutics, Inc Pet Cancer Therapeutics Product and Service
-
14.3 Zoetis
-
14.3.1 Zoetis Company Details
-
14.3.2 Zoetis Pet Cancer Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
14.3.3 Zoetis Pet Cancer Therapeutics Product and Service
-
14.4 AB Science
-
14.4.1 AB Science Company Details
-
14.4.2 AB Science Pet Cancer Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
14.4.3 AB Science Pet Cancer Therapeutics Product and Service
-
14.5 Aratana Therapeutics, Inc
-
14.5.1 Aratana Therapeutics, Inc Company Details
-
14.5.2 Aratana Therapeutics, Inc Pet Cancer Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
14.5.3 Aratana Therapeutics, Inc Pet Cancer Therapeutics Product and Service
-
14.6 Zenoaq
-
14.6.1 Zenoaq Company Details
-
14.6.2 Zenoaq Pet Cancer Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
14.6.3 Zenoaq Pet Cancer Therapeutics Product and Service
-
14.7 Rhizen Pharmaceutical SA
-
14.7.1 Rhizen Pharmaceutical SA Company Details
-
14.7.2 Rhizen Pharmaceutical SA Pet Cancer Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
14.7.3 Rhizen Pharmaceutical SA Pet Cancer Therapeutics Product and Service
-
14.8 Boehringer Ingelheim International GmbH
-
14.8.1 Boehringer Ingelheim International GmbH Company Details
-
14.8.2 Boehringer Ingelheim International GmbH Pet Cancer Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
14.8.3 Boehringer Ingelheim International GmbH Pet Cancer Therapeutics Product and Service
-
14.9 Oasmia Pharmaceuticals AB
-
14.9.1 Oasmia Pharmaceuticals AB Company Details
-
14.9.2 Oasmia Pharmaceuticals AB Pet Cancer Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
14.9.3 Oasmia Pharmaceuticals AB Pet Cancer Therapeutics Product and Service
-
14.10 Regeneus Ltd
-
14.10.1 Regeneus Ltd Company Details
-
14.10.2 Regeneus Ltd Pet Cancer Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
14.10.3 Regeneus Ltd Pet Cancer Therapeutics Product and Service
-
14.11 VetDC, Inc
-
14.11.1 VetDC, Inc Company Details
-
14.11.2 VetDC, Inc Pet Cancer Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
14.11.3 VetDC, Inc Pet Cancer Therapeutics Product and Service
15 Appendix
TABLE OF CHARTS
-
Table Definition of Pet Cancer Therapeutics
-
Figure Pet Cancer Therapeutics Picture
-
Table Global Pet Cancer Therapeutics Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Pet Cancer Therapeutics Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Pet Cancer Therapeutics Market: Year-over-year Growth 2022 - 2028 (%)
-
Table Parent Market Analysis
-
Figure Parent Market Price
-
Table Related/Ancillary Market Outlook Analysis
-
Table Supplier Power Analysis
-
Table Buyer Power Analysis
-
Table Substitution Threat Analysis
-
Table Threat of New Entrants Analysis
-
Table Competitive Rivalry Analysis
-
Figure Global Pet Cancer Therapeutics Consumption by Country (2017-2022)
-
Figure United States Pet Cancer Therapeutics Consumption and Growth Rate (2017-2022)
-
Table Europe Pet Cancer Therapeutics Consumption and Growth Rate (2017-2022)
-
Figure China Pet Cancer Therapeutics Consumption and Growth Rate (2017-2022)
-
Figure Japan Pet Cancer Therapeutics Consumption and Growth Rate (2017-2022)
-
Figure India Pet Cancer Therapeutics Consumption and Growth Rate (2017-2022)
-
Figure South Korea Pet Cancer Therapeutics Consumption and Growth Rate (2017-2022)
-
Figure Global Pet Cancer Therapeutics Consumption Forecast by Country (2022-2028)
-
Figure United States Pet Cancer Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe Pet Cancer Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
Figure China Pet Cancer Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan Pet Cancer Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
Figure India Pet Cancer Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea Pet Cancer Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Chemotherapy Consumption and Growth Rate (2017-2022)
-
Figure Global Targeted Therapy Consumption and Growth Rate (2017-2022)
-
Figure Global Combination Therapy Consumption and Growth Rate (2017-2022)
-
Figure Global Immunotherapy Consumption and Growth Rate (2017-2022)
-
Figure Global Immunotherapy Consumption and Growth Rate (2017-2022)
-
Figure Global Immunotherapy Consumption and Growth Rate (2017-2022)
-
Figure Global Immunotherapy Consumption and Growth Rate (2017-2022)
-
Figure Global Immunotherapy Consumption and Growth Rate (2017-2022)
-
Figure Global Immunotherapy Consumption and Growth Rate (2017-2022)
-
Figure Global Immunotherapy Consumption and Growth Rate (2017-2022)
-
Figure Global Immunotherapy Consumption and Growth Rate (2017-2022)
-
Figure Global Chemotherapy Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Targeted Therapy Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Combination Therapy Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Immunotherapy Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Immunotherapy Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Immunotherapy Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Immunotherapy Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Immunotherapy Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Immunotherapy Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Immunotherapy Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Immunotherapy Consumption Forecast and Growth Rate (2022-2028)
-
Table Global Pet Cancer Therapeutics Import by Region (Top 5 Countries) (2017-2028)
-
Table Global Pet Cancer Therapeutics Export by Region (Top 5 Countries) (2017-2028)
-
Table Morphogenesis, Inc (Foundation Year, Company Profile and etc.)
-
Table Morphogenesis, Inc Pet Cancer Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
Table Morphogenesis, Inc Pet Cancer Therapeutics Product and Service
-
Table Karyopharm Therapeutics, Inc (Foundation Year, Company Profile and etc.)
-
Table Karyopharm Therapeutics, Inc Pet Cancer Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
Table Karyopharm Therapeutics, Inc Pet Cancer Therapeutics Product and Service
-
Table Zoetis (Foundation Year, Company Profile and etc.)
-
Table Zoetis Pet Cancer Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
Table Zoetis Pet Cancer Therapeutics Product and Service
-
Table AB Science (Foundation Year, Company Profile and etc.)
-
Table AB Science Pet Cancer Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
Table AB Science Pet Cancer Therapeutics Product and Service
-
Table Aratana Therapeutics, Inc (Foundation Year, Company Profile and etc.)
-
Table Aratana Therapeutics, Inc Pet Cancer Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
Table Aratana Therapeutics, Inc Pet Cancer Therapeutics Product and Service
-
Table Zenoaq (Foundation Year, Company Profile and etc.)
-
Table Zenoaq Pet Cancer Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
Table Zenoaq Pet Cancer Therapeutics Product and Service
-
Table Rhizen Pharmaceutical SA (Foundation Year, Company Profile and etc.)
-
Table Rhizen Pharmaceutical SA Pet Cancer Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
Table Rhizen Pharmaceutical SA Pet Cancer Therapeutics Product and Service
-
Table Boehringer Ingelheim International GmbH (Foundation Year, Company Profile and etc.)
-
Table Boehringer Ingelheim International GmbH Pet Cancer Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
Table Boehringer Ingelheim International GmbH Pet Cancer Therapeutics Product and Service
-
Table Oasmia Pharmaceuticals AB (Foundation Year, Company Profile and etc.)
-
Table Oasmia Pharmaceuticals AB Pet Cancer Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
Table Oasmia Pharmaceuticals AB Pet Cancer Therapeutics Product and Service
-
Table Regeneus Ltd (Foundation Year, Company Profile and etc.)
-
Table Regeneus Ltd Pet Cancer Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
Table Regeneus Ltd Pet Cancer Therapeutics Product and Service
-
Table VetDC, Inc (Foundation Year, Company Profile and etc.)
-
Table VetDC, Inc Pet Cancer Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
Table VetDC, Inc Pet Cancer Therapeutics Product and Service
-
